Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trial
Article in European Journal of Cancer (January 2023)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in European Journal of Cancer (January 2023)
Article in Evidence-based Complementary and Alternative Medicine (August 2022)
Article in The Oncologist (March 2022)